Amedeo Smart

Free Medical Literature Service



Multiple Sclerosis

  Free Subscription


1 Arch Phys Med Rehabil
1 Can J Neurol Sci
1 J Neurol
8 Mult Scler
1 Nat Med
2 Nat Rev Neurol
1 Neurol Clin Pract
2 Rev Neurol (Paris)

    Arch Phys Med Rehabil

  1. MONAGHAN PG, Daugherty AM, Fritz NE
    Establishing the Reliability of The Step Test Evaluation of Performance on Stairs (STEPS) in Multiple Sclerosis.
    Arch Phys Med Rehabil. 2024 Apr 6:S0003-9993(24)00909.
    >> Share

    Can J Neurol Sci

  2. BALCOM EF, McCombe JA, Kate M, Vu K, et al
    Geographical variation in medication and health resource use in multiple sclerosis.
    Can J Neurol Sci. 2024 Apr 11:1-21. doi: 10.1017/cjn.2024.
    >> Share

    J Neurol

  3. STALTER J, Pars K, Witt K
    Accelerated long-term forgetting reveals everyday memory deficits in early-stage multiple sclerosis.
    J Neurol. 2024 Apr 8. doi: 10.1007/s00415-024-12359.
    >> Share

    Mult Scler

  4. KLISTORNER S, Barnett MH, Wang C, Parratt J, et al
    Longitudinal enlargement of choroid plexus is associated with chronic lesion expansion and neurodegeneration in RRMS patients.
    Mult Scler. 2024;30.
    >> Share

  5. REEVES JA, Mohebbi M, Wicks T, Salman F, et al
    Paramagnetic rim lesions predict greater long-term relapse rates and clinical progression over 10 years.
    Mult Scler. 2024;30.
    >> Share

  6. TUR C, Battiston M, Yiannakas MC, Collorone S, et al
    What contributes to disability in progressive MS? A brain and cervical cord-matched quantitative MRI study.
    Mult Scler. 2024;30.
    >> Share

  7. 'T HART BA, van Luijn MM
    EBV infection drives MS pathology: No.
    Mult Scler. 2024;30.
    >> Share

  8. SCHNEIDER M, Kramer J, Banks A, Moses H, et al
    New onset lymphopenia in patients with relapsing multiple sclerosis switching from long-standing dimethyl fumarate treatment to diroximel fumarate: A case series.
    Mult Scler. 2024 Apr 11:13524585241242027. doi: 10.1177/13524585241242027.
    >> Share

  9. MOCCIA M, Terracciano D, Brescia Morra V, Castaldo G, et al
    Neurofilament in clinical practice: Is the multiple sclerosis community ready?
    Mult Scler. 2024 Apr 11:13524585241246536. doi: 10.1177/13524585241246536.
    >> Share

  10. ALOISI F, Salvetti M
    EBV infection drives MS pathology: Yes.
    Mult Scler. 2024;30.
    >> Share

  11. CORTESE M, Ascherio A
    EBV infection drives MS pathology: Commentary.
    Mult Scler. 2024;30.
    >> Share

    Nat Med

  12. ARNOLD C
    'Inverse vaccines' could treat autoimmune disease - from multiple sclerosis to celiac disease.
    Nat Med. 2024 Apr 10. doi: 10.1038/d41591-024-00024.
    >> Share

    Nat Rev Neurol

  13. WOOD H
    EBV-specific T cells in multiple sclerosis.
    Nat Rev Neurol. 2024 Apr 10. doi: 10.1038/s41582-024-00959.
    >> Share

  14. WOOD H
    BTK inhibitor falters in multiple sclerosis trials.
    Nat Rev Neurol. 2024 Apr 10. doi: 10.1038/s41582-024-00958.
    >> Share

    Neurol Clin Pract

  15. GRAHAM EL, Bove R, Costello K, Crayton H, et al
    Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths.
    Neurol Clin Pract. 2024;14:e200253.
    >> Share

    Rev Neurol (Paris)

  16. LERAY E, Regaert C, Duguet E, Guillaume S, et al
    Impact of multiple sclerosis on employment and income: Insights from a random sample representative of private sector employees in France using longitudinal administrative data.
    Rev Neurol (Paris). 2024 Apr 5:S0035-3787(24)00479.
    >> Share

  17. FREEMAN SA, Zephir H
    Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy.
    Rev Neurol (Paris). 2024 Apr 9:S0035-3787(24)00474.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016